Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma…
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent…
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Finance
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows…
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Featured
Page 41
Featured
Featured posts
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing Deal
Kate Hudson
-
May 1, 2024
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) Amidst Groundbreaking Cancer Therapy Innovations
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks Investor Excitement”
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial Hypertension
SPY puts are still Wall Street’s favorite
Gavins Felicity
-
February 26, 2020
0
Stocks Making News as CDC Warns Coronavirus Rapidly Evolving and Expanding...
Matt Wade
-
February 25, 2020
0
Canopy Growth Corp (NYSE:CGC) technical alert
Matt Wade
-
February 21, 2020
0
Markets continue their upward march unabated
Kate Hudson
-
February 11, 2020
0
Dow Jones Industrial Average climbs up on corona virus updates
Kate Hudson
-
February 10, 2020
0
1
...
40
41
42
43
Page 41 of 43
Recent Post
Sezzle (NASDAQ: SEZL) Shares Surge on Robust Q1 Earnings and Upgraded...
Kate Hudson
-
May 9, 2024
0
Sezzle Inc. (NASDAQ:SEZL) saw its stock price increase today primarily due to its strong first-quarter financial performance for 2024. The company reported...
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows...
May 8, 2024
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma...
May 7, 2024
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent...
May 2, 2024
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
May 1, 2024